- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04782492
IVUS Study for SV Graft: Y-composite vs Aortocoronary Conduit (CONFIG)
Morphologic Changes of the Saphenous Vein as Y-composite Graft Based on the Left Internal Thoracic Artery Versus Aortocoronary Conduit for Coronary Artery Bypass Grafting: A Prospective Randomized Controlled Trial
Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG.
In our institution, saphenous vein has been primarily used for the second graft and we have harvested it with 'No touch technique'. We have been demonstrated the excellent long-term patency of this 'No touch saphenous vein' in many studies. However, it is still unknown which configuration is the better strategy for the saphenous vein as a Y-composite graft based on the left internal thoracic artery versus an aortocoronary conduit. Thus, we aimed to evaluate morphologic change of saphenous vein graft by 1-year intravascular ultrasound (IVUS) study and angiographic patency results between Y-composite graft and aortocoronary conduit.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The enrolled patient underwent routine sternotomy, and left internal thoracic artery (LITA) and saphenous vein (SV) are harvested. After harvest, the patient is randomized to Y-composite group or aortocoronary group.
For Y-composite group, SV is anastomosed to LITA as Y-composite fashion. Then, LITA is anastomosed to left anterior descending artery. SV is anastomosed to the rest of the target vessels with sequential anastomosis technique (e.g. diagonal branch, obtuse marginal branch, posterolateral branch and posteriori descending artery).
For aortocoronary group, LITA is anastomosed to left anterior descending artery. Then, SV is anastomosed to ascending aorta using proximal anastomosis assist device without clamping the aorta. SV is anastomosed to the rest of the target vessels with sequential anastomosis technique (e.g. diagonal branch, obtuse marginal branch, posterolateral branch and posteriori descending artery).
After completion of anastomoses, residual portion of distal SV is collected for microscopic evaluation and measurement of intima-media thickness.
At the 1-year follow-up, IVUS study, in addition to coronary angiography, is performed to evaluate the morphologic changes and measure intima-media thickness of the saphenous vein graft.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- A patient who is going to receive coronary artery bypass grafting
- Older than 19 years
- Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft
Exclusion Criteria:
- Other concomitant procedures (e.g. valve or aorta surgery) is planned
- Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer)
- Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Y-composite graft
The saphenous vein is anastomosed to the middle portion of the left internal thoracic artery as Y-composite fashion.
Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery.
Other native coronary arterial targets are bypassed with saphenous vein graft.
|
Saphenous vein could be used as Y-composite graft or aortocoronary conduit during coronary artery bypass grafting
|
Active Comparator: aortocoronary conduit
The saphenous vein is anastomosed to the ascending aorta as aortocoronary fashion.
Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery.
Other native coronary arterial targets are bypassed with saphenous vein graft.
|
Saphenous vein could be used as Y-composite graft or aortocoronary conduit during coronary artery bypass grafting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intima-media thickness (IMT)
Time Frame: at postoperative 1 year
|
Intima-media thickness measured by intravascular ultrasound (IVUS)
|
at postoperative 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac death
Time Frame: at postoperative 1 year
|
Any death related to cardiac events, including sudden death during follow-up
|
at postoperative 1 year
|
Lumen diameter (LD)
Time Frame: at postoperative 1 year
|
Lumen diameter measured by intravascular ultrasound (IVUS)
|
at postoperative 1 year
|
Graft patency
Time Frame: at postoperative 1 year
|
Graft patency measured by coronary angiography
|
at postoperative 1 year
|
All cause mortality
Time Frame: at postoperative 1 year
|
all deaths from any cause
|
at postoperative 1 year
|
Target vessel revascularization
Time Frame: at postoperative 1 year
|
The number of patients who received any intervention performed for the previously bypassed target vessel during follow-up
|
at postoperative 1 year
|
Reintervention
Time Frame: at postoperative 1 year
|
The number of patients who received any coronary intervention performed during follow-up due to the coronary artery disease
|
at postoperative 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ho Young Hwang, MD, PhD, Seoul National University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2101-143-1191
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on graft configuration in coronary artery bypass grafting
-
University of OuluKarolinska Institutet; Universita di Verona; University of Campania "Luigi Vanvitelli... and other collaboratorsRecruitingMyocardial Infarction | Coronary Artery Disease | Angina PectorisFinland
-
Ajou University School of MedicineActive, not recruitingMyocardial Infarction | Obesity Associated DisorderKorea, Republic of
-
University of WuerzburgDeutsche Stiftung für HerzforschungUnknownStroke | Coronary Heart Disease | Cerebral InfarctionGermany
-
University Medical Center GroningenUnknownCoronary Artery Bypass | Cognitive DysfunctionNetherlands
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Far Eastern Memorial HospitalCompletedCoronary Artery Disease
-
Tomsk National Research Medical Center of the Russian...Russian Science FoundationRecruitingCoronary Artery Disease | Heart FailureRussian Federation
-
Austin HealthActive, not recruitingCoronary Artery Disease | AtherosclerosisAustralia
-
Armed Forces Institute of Cardiology, PakistanCompleted
-
Region Örebro CountySwedish Heart Lung Foundation; Regional Clinical ResearchCompleted